search
Back to results

Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox

Primary Purpose

Gingival Overgrowth

Status
Unknown status
Phase
Phase 1
Locations
Study Type
Interventional
Intervention
Botox Injectable Product
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gingival Overgrowth

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Gummy smile more than 3mm.
  2. Adults >18 years.
  3. Non-smokers.
  4. Patients with healthy systemic condition
  5. Normal clinical crown dimensions.
  6. Good oral hygiene.

Exclusion Criteria:

  1. Natural dentition upper anterior
  2. Pregnant or lactating women.
  3. Patients with inflamed gingiva or gingival enlargement.
  4. Inflammation or infection at the site of injection.
  5. Patients with allergy to botulinum toxin, lactose, and albumin.
  6. Concurrent use of aminoglycoside antibiotic that enhances the action of the toxin. (Jaspers, Pijpe, & Jansma, 2011)
  7. < 3 mm attached gingivae that might create difficulties in flap design, stabilization and suturing.
  8. Patients using anticholinesterase or other agents interfering with neuromuscular transmission

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    lip repositioning technique with Botox injection.

    lip repositioning technique.

    Arm Description

    Botulinum toxin produces partial chemical denervation of the muscle resulting in localized reduction in muscle activity (Binder et al., 1998). Therefore, the technique is a useful adjunct in the esthetic improvement of the smile and provides better results when combined with resective gingival surgery(Pedron & Mangano, 2018).

    Lip repositioning aims to limit the retraction of elevator smile muscles. Lip repositioning results in a shallow vestibuler restricting of the muscle pull; Thereby limiting the gingival display during smiling.(Makkiah, 2017) It is a less invasive, viable substitute for patients, has fewer post-operative complications and provides a faster recovery compared to orthognathic surgery(Grover, Gupta, & Luthra, 2014).

    Outcomes

    Primary Outcome Measures

    change in amount of gingival display
    Amount of gingival display (from the inferior border of the upper lip vermillion border to the gingival margin of the central incisor) will be assessed from clinical photographs obtained during active smile, with a mm ruler in place

    Secondary Outcome Measures

    Patient satisfaction: quesionnaire
    On the first follow-up visits, each patient from both groups answered a questionnaire addressing the following aspects: The overall appearance. Rate the improvement of their smile according to a 5-point aesthetic scale (5 = excellent, 4 = very good, 3 good, 2 = fair, 1 = poor). Their willingness to repeat the treatment.

    Full Information

    First Posted
    July 18, 2019
    Last Updated
    July 23, 2019
    Sponsor
    Cairo University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04030767
    Brief Title
    Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox
    Official Title
    Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox: a Randomized Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 20, 2019 (Anticipated)
    Primary Completion Date
    September 20, 2020 (Anticipated)
    Study Completion Date
    September 20, 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cairo University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No

    5. Study Description

    Brief Summary
    Since the introduction of the lip repositioning procedure by a number of modifications to the technique have been introduced. All these modifications were made to prevent the main complication of lip repositioning surgeries 'relapse'. Relapse was found to occur in 8% of the cases treated . Botox injections have been suggested as a possible treatment for cases with relapse Botox acts by blocking muscular activity, however, Botulinum toxin technique has a transitory effect (6-7 months). . By combining Botox as a pretreatment and lip repositioning surgery, Botox injections maybe a useful adjunct in improving and stabilizing the results of achieved, by paralyzing the muscles during the healing period. There are no studies, to the investigator's knowledge, exploring the use of botox combined with lip repositioning to decrease muscle pull and therefore decrease the relapse.
    Detailed Description
    Normal gingival display has been defined by as the gum exposure between the inferior border of upper lip and gingival margin of anterior central incisors when smiling. An exposure of gingiva around 0-2 mm when smiling, and 2-4 mm of the maxillary incisor edges when the lips are at the rest state are considered as acceptable. While more than 2 mm of gingival exposure when a person smiles is stated by experts as an excessive gingival display, or what is known as "Gummy Smile",which is more of a descriptive term than a diagnosed condition, and affects a notable proportion of the population, especially women who are affected more than men. Many studies have stated the main causes of excessive gingival display, presenting the most important factors which may lead to having a gummy Smile. The study of Roe described that lip length and the upper lip mobility rate are the main contributing factors. The previous research stated that the exposure of teeth and gingiva depends on the integrated effects of a number of variables (increased muscle capacity, vertical maxillary excess, greater inter-labial gap at resting position, and the amount of over-jet and over-bite). Pausch & Katsoulis mentioned that abnormal gingival and maxillary anterior teeth display may take place due to numerous anatomic or functional factors, either hereditary or inborn. A narrow upper lip, an irregular eruption of teeth, excessive protuberance or vertical maxillary growth, and hypermobility of the maxillary lip and elevator muscle are common reasons for a gummy Smile. In fact, several contributing factors are affecting individuals to have a gummy Smile. Sometimes one of them is presented, although in some cases more than only one cause can be seen. Correct diagnosis of the reason leads to a proper treatment plan. Excessive gingival display can be managed by a variety of procedures. These procedures include surgical and non-surgical methods The underlying cause of excessive gingival display or gummy Smile has the main effect on the type of procedure that will be performed.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Gingival Overgrowth

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 1
    Interventional Study Model
    Parallel Assignment
    Model Description
    Randomized Controlled Clinical Trial: Parallel group, two arm, non-inferiority trial with 1:1 allocation ratio.
    Masking
    Investigator
    Masking Description
    Single blinded: Blinding of the participants is not applicable. Blinding of the operator is not applicable. Outcome assessor (primary and secondary outcomes) & biostatistician will be blinded.
    Allocation
    Randomized
    Enrollment
    22 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    lip repositioning technique with Botox injection.
    Arm Type
    Experimental
    Arm Description
    Botulinum toxin produces partial chemical denervation of the muscle resulting in localized reduction in muscle activity (Binder et al., 1998). Therefore, the technique is a useful adjunct in the esthetic improvement of the smile and provides better results when combined with resective gingival surgery(Pedron & Mangano, 2018).
    Arm Title
    lip repositioning technique.
    Arm Type
    Active Comparator
    Arm Description
    Lip repositioning aims to limit the retraction of elevator smile muscles. Lip repositioning results in a shallow vestibuler restricting of the muscle pull; Thereby limiting the gingival display during smiling.(Makkiah, 2017) It is a less invasive, viable substitute for patients, has fewer post-operative complications and provides a faster recovery compared to orthognathic surgery(Grover, Gupta, & Luthra, 2014).
    Intervention Type
    Drug
    Intervention Name(s)
    Botox Injectable Product
    Other Intervention Name(s)
    Xeomin
    Intervention Description
    Botulinum toxin produces partial chemical denervation of the muscle resulting in localized reduction in muscle activity
    Primary Outcome Measure Information:
    Title
    change in amount of gingival display
    Description
    Amount of gingival display (from the inferior border of the upper lip vermillion border to the gingival margin of the central incisor) will be assessed from clinical photographs obtained during active smile, with a mm ruler in place
    Time Frame
    recorded at baseline, 3, 6 ,9 months and 1 year
    Secondary Outcome Measure Information:
    Title
    Patient satisfaction: quesionnaire
    Description
    On the first follow-up visits, each patient from both groups answered a questionnaire addressing the following aspects: The overall appearance. Rate the improvement of their smile according to a 5-point aesthetic scale (5 = excellent, 4 = very good, 3 good, 2 = fair, 1 = poor). Their willingness to repeat the treatment.
    Time Frame
    o The level of satisfaction during the followed periods (after two weeks, after two months, after six months)

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Gummy smile more than 3mm. Adults >18 years. Non-smokers. Patients with healthy systemic condition Normal clinical crown dimensions. Good oral hygiene. Exclusion Criteria: Natural dentition upper anterior Pregnant or lactating women. Patients with inflamed gingiva or gingival enlargement. Inflammation or infection at the site of injection. Patients with allergy to botulinum toxin, lactose, and albumin. Concurrent use of aminoglycoside antibiotic that enhances the action of the toxin. (Jaspers, Pijpe, & Jansma, 2011) < 3 mm attached gingivae that might create difficulties in flap design, stabilization and suturing. Patients using anticholinesterase or other agents interfering with neuromuscular transmission

    12. IPD Sharing Statement

    Learn more about this trial

    Evaluating Lip Repositioning for the Treatment of Excess Gingival Display With and Without Pretreatment With Botox

    We'll reach out to this number within 24 hrs